Recent progress in the management of advanced renal cell carcinoma.
about
Prognostic Value of High CXCR4 Expression in Renal Cell Carcinoma: A System Review and Meta-AnalysisNon-steroidal anti-inflammatory drugs in the treatment of genitourinary malignancies: focus on clinical data.Evaluation of everolimus in renal cell cancer.Clinical outcomes in patients with metastatic renal cell carcinoma receiving everolimus or temsirolimus after sunitinib.Skewed T-helper (Th)1/2- and Th17/T regulatory‑cell balances in patients with renal cell carcinoma.Indirect treatment comparison of bevacizumab + interferon-α-2a vs tyrosine kinase inhibitors in first-line metastatic renal cell carcinoma therapy.Clinical experience with temsirolimus in the treatment of advanced renal cell carcinomaSurvival among patients with advanced renal cell carcinoma in the pretargeted versus targeted therapy erasBile acid exposure up-regulates tuberous sclerosis complex 1/mammalian target of rapamycin pathway in Barrett's-associated esophageal adenocarcinoma.Activity of XL184 (Cabozantinib), an oral tyrosine kinase inhibitor, in patients with medullary thyroid cancer.Current status of cytoreductive nephrectomy in metastatic renal cell carcinoma.Myeloid-derived suppressor cells adhere to physiologic STAT3- vs STAT5-dependent hematopoietic programming, establishing diverse tumor-mediated mechanisms of immunologic escape.A case study of back pain and renal cell carcinoma.Does arterial spin-labeling MR imaging-measured tumor perfusion correlate with renal cell cancer response to antiangiogenic therapy in a mouse model?Autologous CIK cell immunotherapy in patients with renal cell carcinoma after radical nephrectomy.Everolimus for the treatment of advanced renal cell carcinoma.Optimizing treatment for patients with metastatic renal cell carcinoma in the Central and Eastern European region.Current status of pharmacotherapy against metastatic renal cell carcinoma in Japan.Clinical studies applying cytokine-induced killer cells for the treatment of renal cell carcinoma.Axitinib Induced Recurrent Pneumothorax following Near-Complete Response of Renal Cell Carcinoma Lung Metastasis: An Unexpected Complication.Cytokine-induced killer cells in the treatment of patients with renal cell carcinoma: a pooled meta-analysis.Axitinib in metastatic renal cell carcinoma: patient characteristics and treatment patterns in US community oncology centers.VHL promotes immune response against renal cell carcinoma via NF-κB-dependent regulation of VCAM-1.Expression of Genes Involved in Porphyrin Biosynthesis Pathway in the Human Renal Cell Carcinoma.Gene microarray analysis of human renal cell carcinoma: the effects of HDAC inhibition and retinoid treatment.Dual Strands of Pre-miR-149 Inhibit Cancer Cell Migration and Invasion through Targeting FOXM1 in Renal Cell Carcinoma.Combination of mTOR and MAPK Inhibitors-A Potential Way to Treat Renal Cell Carcinoma.Complete Response to Sorafenib Rechallenge in a Patient with Metastatic Renal Cell Carcinoma.Identification of alternatively spliced GRIM-19 mRNA in kidney cancer tissues.A population-based study examining the effect of tyrosine kinase inhibitors on survival in metastatic renal cell carcinoma in Alberta and the role of nephrectomy prior to treatment.Efficacy of targeted therapy for advanced renal cell carcinoma: a systematic review and meta-analysis of randomized controlled trials.CBFA2T2 is associated with a cancer stem cell state in renal cell carcinoma.Treatment of renal cell carcinoma: Current status and future directions.Phase 1 dose-escalation trial of tremelimumab plus sunitinib in patients with metastatic renal cell carcinomaTremelimumab (CP-675,206): a fully human anticytotoxic T lymphocyte-associated antigen 4 monoclonal antibody for treatment of patients with advanced cancers
P2860
Q26777376-F176A545-483B-4749-870E-FA76F1E54D41Q33304363-7F1DB5DA-01EE-4F25-9130-B4DE7244E3B9Q33407015-253E6622-8E8E-4E02-85ED-9474C82BC290Q34660799-26C30C3D-0C9C-4979-8C47-F9C1E7C1EAAAQ34673660-8484128D-39A7-452A-86CD-D9AF348FC474Q35205445-4C4874FA-1711-4D38-9E93-7A1F8E64541FQ35797388-AAF0FE89-151D-4F50-97C9-AD347CD59A66Q36528402-612DD65B-62AC-4DC1-83EF-6F1E26577A98Q36649565-24DFB39A-01E3-4EB6-9956-7C2C3178245AQ36822111-C826B2E0-D5A3-4F33-84E9-BF942B417C05Q37025955-CBD8393F-61FC-4A90-9301-4E9B0EC5FFC5Q37066106-75DDC6B7-63DB-4F5B-B04F-09835CA9C764Q37108017-A0F41D40-CF98-46CB-90E8-455CCF95C6F9Q37205008-50310518-31E1-4F23-A196-3CA58B654735Q37412513-0681AA1C-9E5E-41B5-99B4-6498CFE018C9Q37862261-5CFBA595-CE32-461D-845C-F3A1D414DDA7Q37971055-1EF6E0DB-4E2E-4040-8C53-3A666CF45FD7Q37997462-C0F86F16-BE80-4232-BA75-0F20D9ABC3D3Q38063500-3E4748D9-D68B-4104-86D7-D7E30B4077D9Q38074659-17F4D0B3-AC46-4508-956B-72CDA5AAA25BQ38245927-9C5B2A0D-AF00-490B-B52C-9CAD3D755CCEQ38686066-818ED5E5-E3DE-49BA-8268-9F841CFABB86Q38714947-D11B3A5E-722A-43D6-8682-956F6C64CCDBQ38846132-E38F7FE8-FB52-45CE-9CA3-AAE69EB52AEFQ39943631-7B183BC5-4146-4F6F-AC27-D94472EE0F06Q41660592-3E9D6B21-6AAC-4DC1-81AB-340F19F007C1Q42705608-224AE51E-EE42-4AA7-9415-E27B9890C189Q42709088-7FD40386-1C6B-4600-B3F3-B193BDCBCFABQ43053400-B0E792B1-5B0E-4DC1-85BF-53A538EA1844Q43074384-5E140F3C-5BDE-403D-8CBC-C0002E3F80EAQ47358265-858014D6-0571-4178-84FF-E25985ABCA9CQ47432809-019E21F8-932D-44AF-9B22-CA714D6E7FF5Q47726014-02323D59-6D41-4DA6-832B-A29CEDD1FBFAQ56899094-AB780149-1A8B-4EE7-B28F-B042CC88F476Q56900377-D45D252D-7760-4565-A2A5-A93EB5E0FD79
P2860
Recent progress in the management of advanced renal cell carcinoma.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Recent progress in the management of advanced renal cell carcinoma.
@ast
Recent progress in the management of advanced renal cell carcinoma.
@en
type
label
Recent progress in the management of advanced renal cell carcinoma.
@ast
Recent progress in the management of advanced renal cell carcinoma.
@en
prefLabel
Recent progress in the management of advanced renal cell carcinoma.
@ast
Recent progress in the management of advanced renal cell carcinoma.
@en
P1433
P1476
Recent progress in the management of advanced renal cell carcinoma.
@en
P2093
Brian I Rini
Jorge A Garcia
P304
P356
10.3322/CANJCLIN.57.2.112
P407
P577
2007-03-01T00:00:00Z